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a  b  s  t  r  a  c  t
Necrotizing fasciitis is a rare and potentially lethal soft tissue infection. We report a case
of  trochanteric femur fracture in a patient who underwent fracture ﬁxation and developed
necrotizing  fasciitis. A literature review on the topic will be addressed.
© 2014 Sociedade Brasileira de Ortopedia e Traumatologia. Published by Elsevier Editora
Ltda.  
Fasciíte  necrosante  pós-osteossíntese  de  fratura  transtrocantérica  do
fêmur
Palavras-chave:
r  e  s  u  m  o
A fasciíte necrosante é uma rara e potencialmente letal infecc¸ão  de partes moles. A seguir,
Este é um artigo Open Access sob a licença de CC BY-NC-NDFasciíte necrosante
Infecc¸ão
Fraturas do quadril
descreveremos  o caso de uma paciente portadora de fratura transtrocantérica do fêmur que
evoluiu com fasciíte necrosante após a osteossíntese da fratura. Uma  revisão da literatura
acerca  do tema será abordada.
© 2014 Sociedade Brasileira de Ortopedia e Traumatologia. Publicado por Elsevier Editora
diagnosis/treatment. The most important variable inﬂuencingFraturas  do fêmur
IntroductionNecrotizing fasciitis is a rare infection, misdiagnosed as a
benign  infection. The physician must have a high degree
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cantérica do fêmur. Rev Bras Ortop. 2014;49:78–81.
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of clinical suspicion for the establishment of an immediate
Este é um artigo Open Access sob a licença de CC BY-NC-NDs EAM. Fasciíte necrosante pós-osteossíntese de fratura transtro-
il.
mortality is the time of surgical debridement.
Orthopedic surgeons are often the ﬁrst to evaluate
patients with necrotizing fasciitis and therefore must be
shed  by  Elsevier  Editora  Ltda.  Este é um artigo Open Access sob a licença de CC BY-NC-ND
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Fig. 1 – Necrotizing fasciitis in left leg.
Fig. 2 – Anterior aspect of the left leg. Extensive necrosis
and  presence of blisters.r e v b r a s o r t o p
nowledgeable of the clinical presentation and treatment.
imely diagnosis, surgical debridement and broad-spectrum
arenteral antibiotic therapy are the keys to proper treatment.
The  objective of this study was  to describe the fatal course
f  a patient who  developed necrotizing fasciitis after osteosyn-
hesis  of transtrochanteric fracture and to review the literature
f  this serious infection.
ase  report
eventy-one year old female with a history of falling in the
athroom.  The patient was  in pain, unable to walk, with
hortening, external rotation and limited range of motion of
he  left leg. Presented with arterial hypertension, diabetes,
ongestive heart failure, liver cirrhosis, schistosomiasis with
ortal  hypertension and thrombocytopenia. Radiographs of
he  pelvis and left hip showed an unstable transtrochanteric
racture (31-A2.2/AO-ASIF).
The  patient was  operated on the fourth day of hospitaliza-
ion after her release of the medical clinic. Relative stability of
he  fracture (osteosynthesis with DHS screw) and postopera-
ive  control in the ICU were  obtained.
On the second day postoperatively, the patient was dis-
harged  from the ICU and started motor physical therapy with
rogressive  partial load with walker. She was  discharged on
he  eighth hospital day.
Six days after discharge, the patient returned to the hospi-
al  complaining of pain in her left leg, with edema, ecchymosis
nd  swelling of the left calf. The duplex scan of the lower
imbs  depicted deep vein thrombosis (DVT) in the left lower
imb.
Anticoagulation with enoxaparin SC, followed by warfarin
O,  was  initiated.
After  two days, the patient reported persistent pain in the
edial  aspect of her left thigh, with fever (38 ◦C). Absence of
kin  changes in the wound.
Laboratory  tests were  requested: hemoglobin: 7.5 g/dL, total
eukocyte:  2400 mm–3 (bands: 7%, segmented: 82%); platelets:
6,000  mm−3, RNI 1.94; APTT: 41/26, PCR: 28.7 mg/dL.
Progression the next day with hypotension (BP:
0  × 40 mmHg), prostration and appearance of blisters on
he  medial aspect of the left thigh. Absence of pain relief
ith  the use of opioids. Started empirical antibiotic therapy
meropenem), with no improvement.
Suspicion of necrotizing fasciitis because of severe pain,
apid  appearance of bullous lesions in her left thigh and refrac-
oriness  to analgesia.
Indication of debridement of the left leg, but the patient
ad  blood dyscrasia (INR 7.36 and PTTA 73/26).
Changing antibiotics to intravenous tigecycline. The
atient was  referred on an emergency basis to the operating
oom  for wide left leg fasciotomy, surgical debridement and
ollection  of material for analysis (Figs. 1–3).
Occurrence of severe septic shock refractory to the use of
mines.  The patient eventually died.The results of blood cultures and samples collected during
urgery  identiﬁed multiresistant A. baumannii/haemolyticus.
he  germ was  only sensitive to trimethoprim-
ulfamethoxazole, tetracycline and tigecycline.
Fig. 3 – Extensive necrosis in the anteromedial aspect of left
thigh.
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Discussion
Necrotizing fasciitis was  described in 1871 by the U.S. Army
surgeon  Joseph Jones. In 1883, Fournier identiﬁed necrotizing
fasciitis  that affects the perineum and external genitalia. But
it  was  Ben Wilson, in 1952, who described the superﬁcial fascia
and  subcutaneous necrosis.
Necrotizing fasciitis follows an injury to the epidermis. In
45%  of cases, it is not possible identify the site of the initial
injury.1–3 The extremities are the most commonly affected
local,  but the involvement of the trunk and perineum is related
to  the high mortality rate.4,5
Patients over 65 years old have the highest incidence of the
disease.1
Initially, the disease presents with a local edema. How-
ever,  with the involvement of the surrounding tissues, local
toxicity  is triggered and simulates a cellulitis. But the patient
presents  with severe pain, disproportionate to the skin lesion.
The  progression of the margins of erythema at greater than
1  cm/h speed is an important signal to the diagnosis in the
early  stages of necrotizing fasciitis.6 With the evolution of the
underlying  necrotic process, serous blisters possibly becoming
hemorrhagic can be observed.
Usually, fever, chills, hypotension, tachycardia, and altered
level  of consciousness are present.2,6
Acute renal failure is present in 35% of patients, coagulopa-
thy  in 29%, acute respiratory failure in 14%, and bacteremia in
46%.7
The burning pain is the most prominent symptom, that
can  be observed in almost 100% of patients with necrotizing
fasciitis.8
The diagnosis is mainly clinical; it is essential that the
physician has a high degree of suspicion. The average time
between  onset of symptoms and diagnosis is 2-4 days.9
WBC  count > 15,400 cells/mm3 and serum level of
sodium < 135 mmol/L have a sensitivity of 90% for necrotizing
fasciitis. The speciﬁcity is 76% and the positive predictive
value is 26%, and that only serves to exclude the disease.10
Phosphocreatin levels > 600 IU/L have 58% sensitivity and
95%  speciﬁcity.11
MRI  has high sensitivity (93–100%) for diagnosis. Liqueﬁed
tissue inﬂammation and edema around the fascia are detected
by  an increased signal on T2-weighted images and absence of
attenuation  of gadolinium in T1.
“The ﬁnger test” is a simple procedure, done under local
anesthesia. The surgeon makes an incision of 2 cm to the
deep  fascia, and his/her gloved ﬁnger is inserted. The pres-
ence  of liqueﬁed subcutaneous tissue, absence of bleeding and
poor  adherence of subcutaneous tissue during blunt dissec-
tion  deﬁne a positive test. A sample of tissue must be resected
and  sent to bacterioscopy, culture and anatomopathological
examination.
Histologically, necrotizing fasciitis is characterized by sup-
purative  focal necrosis of fascia, fat and nerves, edema of the
ﬁbrous  septa and inﬁltration by polymorphonuclear cells.
The  parenteral empirical antibiotic therapy can be initi-
ated  with imipenem, meropenem, ampicillin/sulbactam or
piperacillin/tazobactam associated with clindamycin. The
antibiotic  is complementary to debridement.
1 1 4;4  9(1):78–81
In patients allergic to penicillin, ceftazidime, associated
with clindamycin, is an option.12
The mortality of necrotizing fasciitis ranges from 6% to
76%.13 Patients over 60 years old have a high mortality rate.
Thrombocytopenia, abnormal liver function, hypoalbumine-
mia,  acute renal failure, and increased serum lactate are
associated with mortality.14
The mortality can reach 100% in non-operated cases and in
the  case of myonecrosis.7 However, the mortality rate drops to
12% if the diagnosis and treatment are made in the ﬁrst four
days  after the onset of symptoms.15
Conclusion
Necrotizing fasciitis is a severe infectious disease. It requires
a  high index of suspicion to initiate antibiotic therapy and
debridement.
Despite  the diagnosis of necrotizing fasciitis and the indi-
cation  of debridement, blood dyscrasias precluded surgery in a
timely manner, so there was no reversal of the clinical picture.
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